Association between Mineral Intake and Cognition Evaluated by Montreal Cognitive Assessment (MoCA): A Cross-Sectional Study.

Ana M Lorenzo-Mora, Ana M López-Sobaler, Laura M Bermejo, Liliana G González-Rodríguez, Esther Cuadrado-Soto, África Peral-Suárez, María Dolores Salas-González, María Luisa Delgado-Losada, Inmaculada C Rodríguez-Rojo, Ana Barabash, Fernando Maestú-Unturbe, Aránzazu Aparicio

Journal: Nutrients 2023;15(21):4505

PMID: 37960158

Abstract

BACKGROUND

Mineral intake may protect against cognitive impairment (CI) and all-cause dementia, which affects a large number of adults worldwide. The aim of this study was to investigate the association between mineral intake and Montreal Cognitive Assessment (MoCA), which is a sensitive and specific test.

METHODS

In total, 201 adults were included in a cross-sectional study. They completed a three-day dietary record to estimate their average daily intake of minerals. Contributions to dietary reference intakes (DRIs) were also calculated. The participants were divided into tertiles according to their mineral intake. CI classifications were determined via the MoCA (score < 26). Apolipoprotein E (APOE) genotyping was carried out, and the patients' anthropometric measurements and physical activity, health and personal data were collected.

RESULTS

The prevalence of CI in this selective sample was 54.2% (34.3% females and 19.9% males). In women, being in the third tertiles of iron and manganese intake was associated with lower odds of having CI (OR [95% CI]: 0.32 [0.11 ± 0.93]; 0.33 [0.12 ± 0.93], < 0.05). No significant differences were observed for any of the nutrients studied in men.

CONCLUSIONS

These findings suggest that a low mineral intake, especially low iron and manganese intake in women, is associated with a worse cognition as assessed by MoCA.

Address: Department of Nutrition and Food Science, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.; VALORNUT Research Group, Complutense University of Madrid, 28040 Madrid, Spain.; San Carlos Health Research Institute (IdISSC), 28040 Madrid, Spain.; School of Sport, Exercise and Health Sciences, Loughborough LE11 3TU, UK.; Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Faculty of Psychology, Complutense University of Madrid, 28223 Madrid, Spain.; Center for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223 Madrid, Spain.; Department of Nursing and Physiotherapy, Faculty of Medicine and Health Sciences, Universidad de Alcalá, 28871 Madrid, Spain.; Faculty of Medicine, Department of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.; Endocrinology and Nutrition Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.